New weekly shot shows promise for obesity and diabetes
NCT ID NCT06567041
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This early study tested a new medicine, NNC0519-0130, given as a weekly shot to help with weight loss and blood sugar control. 82 adults with obesity or type 2 diabetes took part. The main goal was to check for side effects and see how the drug works in the body, with a focus on safety and changes in weight and heart activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International GmbH
Berlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.